Vietnam Pharma Equipment Export Spotlight
Vietnam's pharma market is expanding fast and moving from WHO-GMP toward PIC/S and EU-GMP. We are the gateway for Chinese pharma equipment into Vietnamese GMP plants: GMP-ready equipment documentation, smooth ACFTA zero-duty import, and on-site IQ/OQ/PQ qualification that gets your buyer through facility inspection.
Why Chinese Equipment Makers Should Target Vietnam
High-growth, import-reliant market
At ~USD 8B in 2025 and on track to exceed USD 10B in 2026 (CAGR ~7%), Vietnam's pharma market still meets only 10–20% of demand locally — raw materials and equipment lean heavily on imports, leaving a large capacity gap.
A GMP-upgrade wave driving equipment demand
About 243 factories meet WHO-GMP nationwide, but only ~29 reach EU-GMP / PIC/S-GMP. Local producers are racing to upgrade to higher tiers, directly pulling demand for GMP-compliant production and QC equipment.
ACFTA / RCEP zero-tariff advantage
Under the ASEAN-China FTA (ACFTA), eligible pharma-related imports carry 0% duty; combined with RCEP and Vietnam's 17 FTAs, Chinese equipment holds a structural landed-cost edge.
Value engineering matches the upgrade curve
Most Vietnamese plants are small-to-mid sized — budget-sensitive yet facing rising compliance bars. Mature, fast-lead-time, cost-effective Chinese machinery fits the transition from manual lines to automated, GMP-compliant production.
Getting Chinese Pharma Equipment Into a Vietnamese GMP Plant
The Drug Administration of Vietnam (DAV) regulates medicines and inspects the buyer's plant against WHO-GMP, progressively aligning toward PIC/S and EU-GMP. It does not register equipment or issue any equipment certificate. The supplier's job is to deliver GMP-ready, fully qualifiable (DQ/IQ/OQ/PQ) machinery so the buyer clears that facility inspection on the first pass.
Pharma machinery falls under HS Chapter 84 (e.g. 8419 drying/sterilizing, 8422 filling/packaging, 8479 individual-function machines). With an ACFTA Form E certificate of origin issued in China, these capital goods typically clear at 0% preferential duty in Vietnam; the machine carries no drug-style import licence and is declared as ordinary goods.
Before shipment, assemble the equipment dossier the buyer needs for WHO-GMP (and its upgrade toward PIC/S & EU-GMP): URS, contact-part material certificates (316L stainless, FDA/food-grade elastomers), surface-finish (Ra) reports, Design Qualification (DQ), and a documented Factory Acceptance Test (FAT).
On arrival, run a Site Acceptance Test (SAT), then complete IQ/OQ/PQ and instrument calibration. During the buyer's GMP inspection, DAV scrutinizes exactly this qualification trail, its traceability and calibration certificates, since it proves the machine runs compliantly under real production conditions.
Pressure equipment such as autoclaves and reactors (>0.7 bar) must undergo safety inspection and registration under MOLISA's QCVN 01:2008/BLĐTBXH and Circular 54/2016/TT-BLĐTBXH (first inspection after install, before first use). Electrical safety/EMC is verified within plant safety compliance; weighing/metrology equipment needs legal metrology verification.
Suppliers already exporting to Vietnam
Chinese pharma-equipment suppliers already engaging Vietnamese buyers with export experience.
Vietnam landed-cost estimates
Landed-cost showcases reflecting ACFTA/RCEP zero-tariff benefits.
Sterility Test Isolator
Total Organic Carbon (TOC) Analyzer
VHP Sterilizer
Filter Integrity Tester
Top categories Vietnam imports
The pharma-equipment categories Vietnam imports most.
Capture Vietnam's GMP-Upgrade Window
The market is expanding, standards are rising, tariffs are at zero — now is the window for Chinese equipment to enter Vietnam. Let SourceMach connect you with vetted Vietnamese buyers and channel partners.